Aliquots - Research Briefs Archive — Page 63 of 86

November 21, 2014

Host sequesters zinc to control stomach bug

Understanding how zinc and the host’s immune response control H. pylori’s cancer-causing potential could suggest new therapeutic strategies to reduce infection and cancer risk.

November 12, 2014

New insight on oral cancer culprits

A new mouse model offers insight into the signaling pathways that control oral cancers – and a platform for testing anticancer therapeutics.

November 11, 2014

Protein “pockets” help ID cancer genes

Vanderbilt investigators have used a computational biology approach to uncover new cancer drivers and biomarkers of anticancer drug response.

November 7, 2014

Overactive stress response in obesity

An overactive stress response contributes to the development of insulin resistance in obese individuals, and blocking it may be therapeutically beneficial.

November 6, 2014

Immune cell activity and melanoma

The activity of a certain factor in immune cells is essential for an anti-tumor response, emphasizing the need to consider the effects of anti-cancer therapies on immune cells.

October 29, 2014

Key to prostate cancer resistance

A combination of two types of therapy may be more effective in treating castration-resistant prostate cancer.